These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28389199)

  • 41. Treatment adherence and BMI reduction are key predictors of HbA1c 1 year after diagnosis of childhood type 2 diabetes in the United Kingdom.
    Candler TP; Mahmoud O; Lynn RM; Majbar AA; Barrett TG; Shield JPH
    Pediatr Diabetes; 2018 Dec; 19(8):1393-1399. PubMed ID: 30175430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
    Salman RA; AlSayyad AS; Ludwig C
    BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes.
    Mukherjee J; Sternhufvud C; Smith N; Bell K; Stott-Miller M; McMorrow D; Johnston S
    J Manag Care Spec Pharm; 2016 May; 22(5):449-66. PubMed ID: 27123909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients.
    Bodegard J; Sundström J; Svennblad B; Östgren CJ; Nilsson PM; Johansson G
    Diabetes Metab; 2013 Sep; 39(4):306-13. PubMed ID: 23871502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.
    Straka RJ; Liu LZ; Girase PS; DeLorenzo A; Chapman RH
    Cardiovasc Diabetol; 2009 Sep; 8():53. PubMed ID: 19781099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resources and organisation in primary health care are associated with HbA
    Husdal R; Rosenblad A; Leksell J; Eliasson B; Jansson S; Jerdén L; Stålhammar J; Steen L; Wallman T; Svensson AM; Thors Adolfsson E
    Prim Care Diabetes; 2018 Feb; 12(1):23-33. PubMed ID: 28964673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin.
    Parker ED; Wittbrodt ET; McPheeters JT; Frias JP
    Diabetes Obes Metab; 2019 Feb; 21(2):227-233. PubMed ID: 30101553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of newly diagnosed adults with type 1 diabetes in the UK and evolution of glycaemic control, body mass index and Charlson comorbidity index over the first 5 years after diagnosis.
    Ramtoola S; Nyeland ME; Jacobsen J; Ploug UJ; Kragh N; Zimmermann E
    Prim Care Diabetes; 2020 Aug; 14(4):349-355. PubMed ID: 31668975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The public economic burden of suboptimal type 2 diabetes control upon taxpayers in Sweden: Looking beyond health costs.
    Kotsopoulos N; Connolly MP; Willis M; Nilsson A; Ericsson Å; Baker-Knight J
    Diabetes Obes Metab; 2022 Jun; 24(6):1038-1046. PubMed ID: 35137507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.
    Sortsø C; Komkova A; Sandbæk A; Griffin SJ; Emneus M; Lauritzen T; Simmons RK
    Diabetologia; 2018 Jun; 61(6):1306-1314. PubMed ID: 29549417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical home implementation and trends in diabetes quality measures for AN/AI primary care patients.
    Smith JJ; Johnston JM; Hiratsuka VY; Dillard DA; Tierney S; Driscoll DL
    Prim Care Diabetes; 2015 Apr; 9(2):120-6. PubMed ID: 25095763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA
    McEwan P; Bennett H; Bolin K; Evans M; Bergenheim K
    Diabet Med; 2018 May; 35(5):557-566. PubMed ID: 29377320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain.
    Díaz-Cerezo S; Romera I; Sicras-Mainar A; López-Simarro F; Dilla T; Artime E; Reviriego J
    Curr Med Res Opin; 2020 Sep; 36(9):1449-1456. PubMed ID: 32643441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery.
    van de Laar AW; de Brauw LM; Meesters EW
    Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depression was associated with younger age, female sex, obesity, smoking, and physical inactivity, in 1027 patients with newly diagnosed type 2 diabetes: a Swedish multicentre cross-sectional study.
    Melin EO; Wanby P; Neumark T; Holmberg S; Neumark AN; Johansson K; Landin-Olsson M; Thulesius H; Hillman M; Thunander M
    BMC Endocr Disord; 2022 Nov; 22(1):273. PubMed ID: 36348470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol.
    Furler JS; Young D; Best J; Patterson E; O'Neal D; Liew D; Speight J; Segal L; May C; Manski-Nankervis JA; Holmes-Truscott E; Ginnivan L; Blackberry ID
    Implement Sci; 2014 Feb; 9():20. PubMed ID: 24528528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
    McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
    J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.